Literature DB >> 12408339

Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy.

Robyne Soper1, Uwe Himmelreich, Dorothy Painter, Ray L Somorjai, Cynthia L Lean, Brion Dolenko, Carolyn E Mountford, Peter Russell.   

Abstract

AIM: Apply the statistical classification strategy (SCS) to magnetic resonance spectroscopy (MRS) data from liver biopsies and test its potential to discriminate between normal liver, cirrhotic nodules and nodules of hepatocellular carcinoma with a high degree of accuracy.
METHODS: Liver tissue specimens from 54 patients undergoing either partial (hemi) or total hepatectomy were analysed by one-dimensional proton MRS at 8.5 Tesla. Histologically, these specimens were confirmed as normal (n=31), cirrhotic (n=59), and hepatocellular carcinoma (HCC, n=32). Diagnostic correlation was performed between the MR spectra and histopathology. An SCS was applied consisting of pre-processing MR magnitude spectra to identify spectral regions of maximal discriminatory value, and cross-validated linear discriminant analysis.
RESULTS: SCS applied to MRS data distinguished normal liver tissue from HCC with an accuracy of 100%. Normal liver tissue was distinguished from cirrhotic liver with an accuracy of 92% and cirrhotic liver was distinguished from HCC with an accuracy of 98%.
CONCLUSIONS: SCS applied to proton MRS of liver biopsies provides a robust method to distinguish, with a high degree of accuracy, HCC from both cirrhotic and normal liver.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408339     DOI: 10.1080/0031302021000009324

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  13 in total

Review 1.  [(1)H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla].

Authors:  F Fischbach; M Thormann; J Ricke
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

Review 2.  Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.

Authors:  Z Yuan; W-T Li; X-D Ye; H-Y Zhu; W-J Peng
Journal:  Clin Transl Oncol       Date:  2013-12-20       Impact factor: 3.405

Review 3.  Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications.

Authors:  Roland Amathieu; Mohamed Nawfal Triba; Corentine Goossens; Nadia Bouchemal; Pierre Nahon; Philippe Savarin; Laurence Le Moyec
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.

Authors:  I Jane Cox; Amar Sharif; Jeremy F L Cobbold; Howard C Thomas; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 5.  In vivo magnetic resonance spectroscopy of liver tumors and metastases.

Authors:  E G W ter Voert; L Heijmen; H W M van Laarhoven; A Heerschap
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

Review 6.  Metabonomic window into hepatitis B virus-related hepatic diseases.

Authors:  Qiang Hou; Zhi-Jun Duan
Journal:  World J Hepatol       Date:  2016-01-08

7.  [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].

Authors:  Lei Zhang; Zhijuan Fan; Hua Kang; Yufan Wang; Shuye Liu; Zhongqiang Shan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

Review 8.  Multiparametric MR Imaging in Abdominal Malignancies.

Authors:  Antonio Luna; Shivani Pahwa; Claudio Bonini; Lidia Alcalá-Mata; Katherine L Wright; Vikas Gulani
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

9.  Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla.

Authors:  F Fischbach; T Schirmer; M Thormann; T Freund; J Ricke; H Bruhn
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

10.  Parametric exploration of the liver by magnetic resonance methods.

Authors:  Paul E Sijens
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.